Epidemiological aspects of upper and lower respiratory tract infections during the COVID-19


DOI: https://dx.doi.org/10.18565/epidem.2022.12.4.72-6

Pshenichnaya N.Yu., Gopatsa G.V., Ugleva S.V., Sergevnin V.I., Kudryavtseva L.G., Lazarkov P.V.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
The review analyzes scientific articles and statistical data on changes in the etiological pattern and epidemiology of upper and lower respiratory tract infections during the COVID-19 pandemic. It is shown that the emergence and spread of SARS-CoV-2 during its pandemic through restrictive measures have affected significantly the global seasonal circulation of respiratory viruses. Uncontrolled and unreasonable use of antibacterial drugs, immunosuppressive therapy for COVID-19, and non-compliance with the anti-epidemic regimen in healthcare facilities have led to a change in the spectrum of community-acquired pneumonia pathogens and to the prevalence of multiresistant opportunistic bacteria and fungal flora as main etiological agents. It is necessary to strengthen the epidemiological surveillance of circulating respiratory viruses and also pathogens that cause lower respiratory tract diseases, as well as to elaborate strategies to combat antimicrobial resistance, and to control their implementation.

Literature


1. Moriyama M., Hugentobler W.J., Iwasaki A. Seasonality of respiratory viral infections. Annu. Rev. Virol. 2020; 7(1): 83–101. DOI: 10.1146/annurev-virology-012420-022445


2. Авдеев С.Н., Белобородов В.Б., Белоцерковский Б.З., Грицан А.И., Дехнич А.В., Зайцев А.А. и др. Тяжелая внебольничная пневмония у взрослых. Клинические рекомендации Федерации анестезиологов и реаниматологов России. Анестезиология и реаниматология 2022; (1): 6–35. DOI: 10.17116/anaesthesiology20220116


Avdeev S.N., Beloborodov V.B., Belocerkovsky B.Z., Grican A.I., Dehnich A.V., Zajcev A.A. et al. [Severe community-acquired pneumonia in adults. Clinical recommendations from Russian Federation of Anaesthesiologists and Reanimatologists]. Anesteziology and reanimatology 2022; (1): 6–35. (In Russ.). DOI: 10.17116/anaesthesiology20220116


3. Tang H.J., Lai C.C., Chao C.M. Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic. Antibiotics 2022; 11(3): 315. doi: 10.3390/antibiotics11030315


4. https://www.iminfin.ru/areas-of-analysis/health


5. Пшеничная Н.Ю., Журавлев Г.Ю., Лизинфельд И.А., Акимкин В.Г., Морозова Н.С., Малеев В.В. Влияние численности населения и географических факторов на заболеваемость острыми респираторными инфекциями в I полугодии 2020 г. в регионах Российской Федерации в период пандемии COVID-19. Эпидемиол. инфекц. болезни. Актуал. вопр. 2021; 11(2): 6–12. DOI: 10.18565/epidem.2021.11.2.6-12


Pshenichnaya N.Yu., Zhuravlev G.Yu., Lizinfel’d I.A., Akimkin V.G., Morozova N.S., Maleev V.V. [The influence of population size and geographical factors on the incidence of acute respiratory infections in the first half of 2020 in the regions of the Russian Federation during the COVID-19 pandemic]. Epidemiоlоgy and infectious diseases. Сurrent items 2021; 11(2): 6–12. (In Russ.). DOI: 10.18565/epidem.2021.11.2.6-12


6. https://www.influenza.spb.ru/system/epidemic_situation/laboratory_diagnostics/


7. Lorini Ch., Bonaccorsi G., Paget J., Caini S. The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature. Int. J. Environ. Res. Public Health 2020; 17(21): 7870. DOI: 10.3390/ijerph17217870


8. Taghioff S.M., Slavin B.R., Holton T., Singh D .Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients. PLoS ONE 2021; 16(8): e0255541. DOI: 10.1371/journal.pone.0255541


9. Conlon А., Ashur С., Washer L., Kim A.E., Hofmann В.А. Impact of the influenza vaccine on COVID-19 infection rates and severity. American journal of infection control. 2021; 49(6): 694–700. DOI: 10.1016/j.ajic. 2021.02.012


10. Ferrero F., Ossorio M.F., Rial M.J. The return of RSV during the COVID‐19 pandemic. Pediatric Pulmonology 2022; 57(3): 770–1. DOI: 10.1002/ppul.25802


11. Kieran D., Goldfarb D.M., Haney J., Amat J.A.R., Herder V. et al. Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology. J. Infect. Dis. 2021; 224(1): 31–8. DOI: 10.1093/infdis/jiab147


12. Torres A., Cilloniz C., Niederman M.S., Menéndez R., Chalmers J.D., Wunderink R.G. et al. Pneumonia. Nat. Rev. Dis. Primers 2021; 7(1): 25. DOI: 10.1038/s41572-021-00259-0.


13. Alibert S., Dela Cruz C.S., Amati F., Sotgiu G., Restrepo M.I. Community-acquired pneumonia. Lancet 2021; 398(10303): 906–19. DOI 10.1016/s0140-6736(21)00630-9


14. Попова А.Ю., Ежлова Е.Б., Демина Ю.В., Носков А.К., Ковалев Е.В., Карпущенко Г.В. и др. Этиология внебольничных пневмоний в период эпидемического распространения COVID-19 и оценка риска возникновения пневмоний, связанных с оказанием медицинской помощи. Здоровье населения и среда обитания 2021; (7): 67–75. DOI:10.35627/2219-5238/2021-29-7-67-75


Popova A.Yu., Ezhlova E.B., Demina Yu.V., Noskov A.K., Kovalev E.V., Karpushchenko G.V. et al. [Etiology of Community-Acquired Pneumonia during the Epidemic Spread of COVID-19 and Healthcare-Associated Pneumonia Risk Assessment]. Public Health and Life Environment 2021; (7): 67–75. (In Russ.). DOI:10.35627/2219-5238/2021-29-7-67-75


15. Троценко О.Е., Бондаренко А.П., Шмыленко В.А., Базыкина Е.А., Пшеничная Н.Ю., Зайцева Т.А. и др. Бактериальная микрофлора респираторного тракта, выявленная у больных внебольничной пневмонией в период продолжающегося распространения новой коронавирусной инфекции в г. Хабаровске (декабрь 2020 – март 2021 г.). Инфекция и иммунитет 2022; 12(4): 713–25. DOI: 10.15789/2220-7619-COR-1839


. Trotsenko O.E., Bondarenko A.P., Shmylenko V.A., Bazykina E.A., Pshenichnaya N.Yu., Zaitseva T.A. et al. [Characteristics of respiratory tract bacterial microflora detected in patients suffering from community-acquired pneumonia during continuing spread of the new coronavirus infection in Khabarovsk city (December 2020 – March 2021)]. Russian Journal of Infection and Immunity 2022; 12(4): 713–725. DOI: 10.15789/2220-7619-COR-1839


About the Autors


Professor Natalia Yu. Pshenichnaya, MD, Deputy Director for Clinical and Analytical Work, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Moscow, Russia; natalia-pshenichnaya@yandex.ru; http://orcid.org/0000-0003-2570-711X
Galina V. Gopatsa, Cand. Med. Sci.; Advisor, Organization and Guidance Department, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Moscow, Russia; galentinabk@mail.ru; https://orcid.org/0000-0001-8703-7671
Svetlana V. Ugleva, MD, Professor, Department of Epidemiology with Courses of Molecular Diagnosis and Disinfectology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; uglevas@bk.ru https://orcid.org/0000-0002-1322-0155


Similar Articles


Бионика Медиа